Ethicon (US) buys into Protein Polymer's closure products
This article was originally published in Clinica
Executive Summary
Ethicon (US) and J&J Development are investing up to $3.3 million in Protein Polymer Technologies' (PPT) surgical adhesives. The development-funding deal gives worldwide marketing rights for surgical tissue adhesives and sealants for wound closure and related applications to Ethicon, while PPT retains an option to manufacture the products.